Palingen, Inc.
Funding rounds
2 counted as startup funding. Open the number of investors for the round's details.
| Month | Raised | Raise | Size | Investors | Sold | Filing |
|---|---|---|---|---|---|---|
| Jun 2023 | $23 M | No. 2 | $10 to $50 million | equity | SEC | |
| Jul 2010 | $1 M | No. 1 | Under $2 million | equity | SEC |
Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.
How it makes money#
What its filings and its own website say, sentence by sentence, each with its source.
Palingen, Inc. had revenue between $1 million and $5 million when it filed its newest notice of a funding round (Jul 2023).
SEC Form D (revenue range) · Jul 2023
The industry group it chose in its notices: Biotechnology.
SEC Form D · Jul 2023
Products and services#
No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).
Investors#
7 named in official filings. Open an investor to see everything it has backed.
| Investor | Kind | Amount | Round | Role | Source |
|---|---|---|---|---|---|
| 667, L.P. | Fund or asset manager | not stated | not stated | Held Series C preferred stock, director (Form 3, 2019) | SEC Form 3 |
| Baker Bros. Advisors (GP) LLC | Fund or asset manager | not stated | not stated | Held Series C preferred stock, director (Form 3, 2019) | SEC Form 3 |
| Baker Bros. Advisors LP | Fund or asset manager | not stated | not stated | Held Series C preferred stock, director (Form 3, 2019) | SEC Form 3 |
| Baker Brothers Life Sciences LP | Fund or asset manager | not stated | not stated | Held Series C preferred stock, director (Form 3, 2019) | SEC Form 3 |
| Haldor Topsoe Holding A/S | Other | not stated | not stated | Held Series B and C preferred stock, 10% owner (Form 3, 2019) | SEC Form 3 |
| Michael D. Loberg | Person | not stated | not stated | Held Series B preferred stock, director (Form 3, 2019) | SEC Form 3 |
| Redmile Group, LLC | Fund or asset manager | not stated | not stated | Held Series C preferred stock, 10% owner, director (Form 3, 2019) | SEC Form 3 |
Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 2 rounds above had up to 7 investors.
Executives and directors
As the company named them in its notices. Directors of a funded startup are often partners of its investors.
| Name | Role | Named in |
|---|---|---|
| Bruce A Keyt | Executive officer | Jul 2023 |
| Chris H. Takimoto | Executive officer | Jul 2023 |
| Fred M. Schwarzer | Executive officer | Jul 2023 |
| George A Gauthier | Executive officer | Jul 2023 |
| Lisa L. Decker | Executive officer | Jul 2023 |
| Misbah A Tahir | Executive officer | Jul 2023 |
| Andrew K Klatt | Executive officer | Jul 2010 |
| Fred M Schwarzer | Executive officer | Jul 2010 |
| Christina Teng Topsoe | Director | Jul 2023 |
| Felix J. Baker | Director | Jul 2023 |
| Fred M. Schwarzer | Director | Jul 2023 |
| Jakob Haldor Topsoe | Director | Jul 2023 |
| Julie J. Hambleton | Director | Jul 2023 |
| M. Kathleen J. Behrens | Director | Jul 2023 |
| Michael J. Lee | Director | Jul 2023 |
| Michael J. Loberg | Director | Jul 2023 |
| William J. Strohl | Director | Jul 2023 |
| Andrew K Klatt | Director | Jul 2010 |
| Fred M Schwarzer | Director | Jul 2010 |
| Nelson K Teng M.D, | Director | Jul 2010 |
| Thomas A Glaze | Director | Jul 2010 |